Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LLY

Recent news which mentions LLY

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Walmart seems to have changed its view of weight-loss drugs
Tickers GIS K KO LLY
Tags DK:NOVO/B WMT NVO
From MarketWatch
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
Tickers ALT JNJ LLY NVO
Tags Small Cap Biotech PFE
From Benzinga
Eli Lilly's Options Frenzy: What You Need to Know
Tickers LLY
Tags Benzinga Options BZI/UOA
From Benzinga
No more exercising? President RFK Jr.? Here’s one bank’s outrageous predictions for 2024
Tickers LLY NVO
Tags AUDJPY USDJPY LLY
From MarketWatch
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
Tickers LLY NVO RHHBY
Tags wegovy Novo Nordisk Eli Lilly & Co/
From Benzinga
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market
Tickers ALT HRTS LLY NVO
Tags Ozempic Health Care Mounjaro
From Benzinga
What the Options Market Tells Us About Eli Lilly
Tickers LLY
Tags LLY Markets Market News
From Benzinga
1 Monster Dividend Stock Growth Investors Should Load Up On Right Now
Tickers LLY
Tags LLY Market News Recent Press Releases
From Motley Fool
You Don't Have to Pick a Winner in Gene-Editing. Do This Instead.
Tickers ARKG BEAM CRBU CRSP
Tags VRTX HOOD ARKG
From Motley Fool
FDA Grants Second Conditional Approval For Eli Lilly's Rare Blood Cancer Drug
Tickers LLY
Tags Health Care Biotech Market News
From Benzinga
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
Tickers LLY NVO RHHBF RHHBY
Tags RHHBF Biotech Market News
From Benzinga
Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk’s Ozempic
Tickers LLY PFE WMT
Tags PFE DK:NOVO/B WMT
From MarketWatch
3 No-Brainer Growth Stocks to Buy in December
Tickers LLY NVO VRTX
Tags NVO Market News Recent Press Releases
From Motley Fool
An Important History Lesson for Gene-Editing Investors
Tickers CRSP LLY NVO PFE
Tags LLY PFE Market News
From Motley Fool
Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk?
Tickers LLY NVO
Tags NVO Recent Press Releases Market News
From Motley Fool
5 Top Stocks to Buy Before 2024
Tickers CRSP ISRG LLY PFE
Tags CRSP VRTX Market News
From Motley Fool
Weight Loss Drugs And Associated Suicidal Thoughts - European Drug Regulator Seeks Clarifications From Drug Makers
Tickers AZN LLY NVO SNY
Tags Health Care LLY Markets
From Benzinga
Weight Loss Drugs - Novo Nordisk A Primary Beneficiary In Obesity Space Currently Controlled By Two Players, Says Analyst
Tickers LLY NVO
Tags Initiation Biotech Price Target
From Benzinga
1 Underrated Reason to Buy Eli Lilly Stock
Tickers LLY
Tags LLY Recent Press Releases Market News
From Motley Fool
If You Invested $100 In This Stock 10 Years Ago, You Would Have $1,200 Today
Tickers LLY
Tags Trading Ideas BZI/POD News
From Benzinga
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
Tickers LLY NVO PFE SPX
Tags SPX PFE DK:NOVO/B
From MarketWatch
Novo Nordisk Sues Florida Compounding Pharmacies Over Impurities In Products Claiming To Contain Wegovy Ingredient
Tickers LLY NVO
Tags Health Care Biotech Market News
From Benzinga
Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy?
Tickers LLY NVO
Tags Recent Press Releases Market News NVO
From Motley Fool
Counterfeit Ozempic Raises Alarms - Lebanon Reports Hypoglycemia Cases
Tickers LLY NVO
Tags Biotech Market News AI Generate
From Benzinga
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?
Tickers LLY NVO
Tags NVO Recent Press Releases Market News
From Motley Fool
Eli Lilly's Options: A Look at What the Big Money is Thinking
Tickers LLY
Tags Market News Markets LLY
From Benzinga
Eli Lilly's Blockbuster Mounjaro Shows Larger, Faster Weight Loss Than Novo Nordisk's Ozempic In Real World Study
Tickers LLY NVO
Tags Market News Equities Biotech
From Benzinga
Novo Nordisk's Flexible Pricing Approach: Push for Broader Access, Innovative Payments
Tickers LLY NVO
Tags Biotech Equities Market News
From Benzinga
Eli Lilly’s Mounjaro three times more effective than Ozempic for weight loss, real-world study finds
Tickers LLY NVO
Tags NVO LLY
From MarketWatch
3 Top Stocks That'll Make Smart Investors Rich
Tickers AMZN CCL CUK LLY
Tags CCL AMZN CUK
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.